Burns Kristie

SEC source: 0001857721-26-000007 · form4-02262026_090232.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,581

F1 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 6,246 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2026 with sale prices ranging from $28.50 to $29.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 5

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,827

F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F6 · price: Reflects the weighted average price of 160 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $28.64 to $28.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 4

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,987

F4 · shares: These shares were sold to cover taxes associated with the settlement of stock units.

F5 · price: Reflects the weighted average price of 4,279 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2026 with sale prices ranging from $27.63 to $28.625 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 3

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,266

F3 · shares: On February 20, 2025, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 7,123 PSUs. Those PSUs are scheduled to vest on the date in 2027 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2026 performance year.

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,143

F2 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 4,058 PSUs. Those earned PSUs vested on February 20, 2026.

SEC source: 0001857721-26-000006 · form4-02242026_100219.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,085

F1 · shares: On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2025. As determined on February 20, 2026, based on actual performance for 2025, the reporting person earned 3,490 PSUs. Those earned PSUs vested on February 20, 2026.

SEC source: 0001857721-26-000004 · form4-02232026_090210.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,595

F1 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

SEC source: 0001857721-26-000002 · form4-01062026_090117.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,401

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 9/11/2025.

SEC source: 0001437749-25-005484 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,540

F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 6,468 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 25, 2025 with sale prices ranging from $14.40 to $14.41 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001437749-25-004936 · rdgdoc.xml · nonDerivative · entry 4

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,008

F5 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F6 · price: Reflects the weighted average price of 4,830 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 24, 2025 with sale prices ranging from $14.4301 to $14.82 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001437749-25-004936 · rdgdoc.xml · nonDerivative · entry 3

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,838

F4 · shares: Represents restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

SEC source: 0001437749-25-004936 · rdgdoc.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,259

F3 · shares: On February 21, 2024, the reporting person was granted PSUs, with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2024. As determined on February 20, 2025, based on actual performance for 2024, the reporting person earned 4,131 PSUs. Those PSUs are scheduled to vest on the date in 2026 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2025 performance year.

SEC source: 0001437749-25-004936 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,128

F1 · shares: On February 22, 2023, the reporting person was granted performance stock units ("PSUs"), with one-third of such PSUs to be earned based on the extent to which certain performance conditions were met for a performance period of 2024. As determined on February 20, 2025, based on actual performance for 2024, the reporting person earned 3,359 PSUs. Those earned PSUs vested on February 20, 2025.

F2 · balance_after: Includes 2,195 shares acquired on May 15, 2024 pursuant to the issuer's employee stock purchase plan.

SEC source: 0001437749-24-015416 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,574

F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F2 · price: Reflects the weighted average price of 815 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 6, 2024 with sale prices ranging from $14.37 to $14.39 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001437749-24-006206 · rdgdoc.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,389

F5 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to a Rule 10b5-1 instructions on February 25, 2021.

F6 · shares: Adoption date of referenced 10b5-1(c) plan is: 02-24-2022.

SEC source: 0001437749-24-006206 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,632

F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to a Rule 10b5-1 instructions on February 24, 2022.

F2 · shares: Adoption date of referenced 10b5-1(c) plan is: 02-24-2022.

F3 · price: Reflects the weighted average price of 1,091 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2024 with sale prices ranging from $15.5707 to $15.615 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4 · balance_after: Includes 1,211 shares acquired under the Company's employee stock purchase plan on November 15, 2023.

SEC source: 0001437749-24-005783 · rdgdoc.xml · nonDerivative · entry 4

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,512

F6 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to Rule 10b5-1 instructions on February 25, 2021 and February 24, 2022.

SEC source: 0001437749-24-005783 · rdgdoc.xml · nonDerivative · entry 3

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,527

F5 · shares: On February 22, 2023, the reporting person was granted PSUs, with the number of PSUs earned to be determined based on the extent to which certain performance conditions are met for a performance period consisting of three separate performance years of 2023, 2024 and 2025. As determined on February 24, 2024, based on actual performance for 2023, the reporting person earned 2,776 PSUs with respect to the 2023 performance year. Those PSUs are scheduled to vest on the date in 2025 that the Compensation and Organization Committee determines the number of PSUs earned with respect to the 2024 performance year.

SEC source: 0001437749-24-005783 · rdgdoc.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,751

F4 · shares: On February 24, 2022, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023. As determined on February 24, 2024, based on actual performance for 2023, the reporting person earned 8,986 PSUs. Of those earned PSUs, one-third, or 2,995 PSUs, vested on February 24, 2024, and the remaining two-thirds, or 5,991 PSUs, are scheduled to vest on February 24, 2025.

SEC source: 0001437749-24-005783 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,765

F1 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units, which sales were pursuant to a Rule 10b5-1 instruction on February 22, 2023.

F2 · shares: Adoption date of referenced 10b5-1(c) plan is: 02-22-2023.

F3 · price: Reflects the weighted average price of 2,249 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 23, 2024 with sale prices ranging from $14.7911 to $14.82 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001437749-24-005437 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,014

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

SEC source: 0001437749-23-013611 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,562

F1 · kind: Adoption date of referenced 10b5-1(c) plan is: 08-31-2021.

F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

SEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 3

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,348

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

SEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,483

F2 · shares: Consists of shares sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 2,162 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on February 27, 2023 with sale prices ranging from $15.3714 to $15.41 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001437749-23-004976 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,645

F1 · shares: On May 5, 2021, the reporting person was granted performance stock units ("PSUs"), with the number of PSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022. As determined on February 25, 2023, based on actual performance for 2022, the reporting person earned 962 PSUs. Of those earned PSUs, one-third, or 320 PSUs, vested on February 25, 2023, and the remaining two-thirds, or 642 PSUs, are scheduled to vest on February 25, 2024.

SEC source: 0001437749-23-004564 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,683

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

SEC source: 0001437749-22-011765 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,959

F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2022.

F2 · shares: The shares were sold to cover taxes associated with the settlement of stock units.

F3 · price: Reflects the weighted average price of 999 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on May 6, 2022 with sale prices ranging from $13.0219 to $13.064 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001437749-22-004751 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,958

F1 · shares: The restricted stock units ("RSUs") vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

SEC source: 0001437749-21-011365 · rdgdoc.xml · derivative · entry 3

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,094

Underlying: Common Stock · 5,094 shares

Expires 2028-05-05

F2 · derivative.exercise_date: One-third of the stock option vests on each of the first three anniversaries of the grant date.

SEC source: 0001437749-21-011365 · rdgdoc.xml · nonDerivative · entry 2

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,777

F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.

SEC source: 0001437749-21-011365 · rdgdoc.xml · nonDerivative · entry 1

Burns Kristie · CIK 0001857721 · Sr. VP Mktg & Clinical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,156

F1 · shares: Restricted stock units ("RSUs") that vest as follows: one-third of the RSUs vest on each of the first three anniversaries of the grant date.